Sands Capital Alternatives, LLC: 13F holdings
CIK 18464442026Q2
| Positions | 24 |
|---|
| Reported value | $613.5m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 24 (+3 vs prior quarter) |
|---|
| Reported value | $613.5m (+45.7%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ALAMAR BIOSCIENCES INC | 4,230,926 | $114.6m | 18.7% |
| NU HLDGS LTD | 7,094,952 | $94.8m | 15.4% |
| KVYO KLAVIYO INC | 3,928,146 | $59.3m | 9.7% |
| BBNX BETA BIONICS INC | 3,708,043 | $58.1m | 9.5% |
| SPYGLASS PHARMA INC | 2,500,012 | $55.7m | 9.1% |
| INHIBIKASE THERAPEUTICS INC | 13,018,965 | $26.4m | 4.3% |
| DASH DOORDASH INC | 127,562 | $23.5m | 3.8% |
| CPNG COUPANG INC | 1,329,314 | $23.1m | 3.8% |
| DDOG DATADOG INC | 80,851 | $21.1m | 3.4% |
| BIOA BIOAGE LABS INC | 786,353 | $19.3m | 3.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1846444")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples